N-methylsansalvamide elicits antitumor effects in colon cancer cells in vitro and in vivo by regulating proliferation, apoptosis, and metastatic capacity
暂无分享,去创建一个
S. Moon | Juhee Park | Chan Lee | S. Moon
[1] Wun-Jae Kim,et al. A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer , 2021, Cancers.
[2] B. Escher,et al. Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test. , 2020, The Science of the total environment.
[3] S. Chutipongtanate,et al. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review) , 2020, International journal of oncology.
[4] E. Ricciotti,et al. Anti-Migratory Effects of 4′-Geranyloxyferulic Acid on LPS-Stimulated U937 and HCT116 Cells via MMP-9 Down-Regulation: Involvement of ROS/ERK Signaling Pathway , 2020, Antioxidants.
[5] Chi-Tang Ho,et al. Cocoa tea (Camellia ptilophylla) induces mitochondria-dependent apoptosis in HCT116 cells via ROS generation and PI3K/Akt signaling pathway. , 2020, Food research international.
[6] E. Giovannucci,et al. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.
[7] G. Lin,et al. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids , 2019, Archives of Toxicology.
[8] Siqi Wu,et al. 8-Cetylcoptisine, a new coptisine derivative, induces mitochondria-dependent apoptosis and G0/G1 cell cycle arrest in human A549 cells. , 2019, Chemico-biological interactions.
[9] D. Schrenk,et al. In vitro metabolism of pyrrolizidine alkaloids - Metabolic degradation and GSH conjugate formation of different structure types. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[10] Jennifer B Dennison,et al. MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway. , 2017, Cancer research.
[11] A. Khanna,et al. 3D engineered In vitro hepatospheroids for studying drug toxicity and metabolism. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[12] Young-Chae Chang,et al. Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells , 2017, PeerJ.
[13] Qing Chen,et al. Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents , 2016, Scientific Reports.
[14] Marco Greco,et al. Worldwide burden of colorectal cancer: a review , 2016, Updates in Surgery.
[15] K. Ghias,et al. Colorectal cancer carcinogenesis: a review of mechanisms , 2016, Cancer biology & medicine.
[16] T. Lassila,et al. Formation of GSH-trapped reactive metabolites in human liver microsomes, S9 fraction, HepaRG-cells, and human hepatocytes. , 2015, Journal of pharmaceutical and biomedical analysis.
[17] F. Tian,et al. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells , 2015, International journal of oncology.
[18] J. Infante,et al. Targeting PI3 kinase in cancer. , 2015, Pharmacology & therapeutics.
[19] Gajendra P. S. Raghava,et al. CancerPPD: a database of anticancer peptides and proteins , 2014, Nucleic Acids Res..
[20] Lucija Peterlin Mašič,et al. Bioactivation potential of thiophene-containing drugs. , 2014, Chemical research in toxicology.
[21] Yang Liu,et al. The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation. , 2014, International journal of oncology.
[22] L. Liu,et al. RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9. , 2013, European review for medical and pharmacological sciences.
[23] Christine Unger,et al. In vitro cell migration and invasion assays. , 2013, Mutation research.
[24] Jyothi Thundimadathil,et al. Cancer Treatment Using Peptides: Current Therapies and Future Prospects , 2012, Journal of amino acids.
[25] Shuang-quan Zhang,et al. Analgesic‐antitumor peptide inhibits proliferation and migration of SHG‐44 human malignant glioma cells , 2011, Journal of cellular biochemistry.
[26] B. Larsen. [Colorectal cancer screening]. , 2010, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[27] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[28] W. Gerwick,et al. Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms. , 2009, Journal of natural products.
[29] Jihe Zhao,et al. Signal transduction by focal adhesion kinase in cancer , 2009, Cancer and Metastasis Reviews.
[30] R. Agarwal,et al. New combination therapies with cell-cycle agents. , 2008, Current opinion in investigational drugs.
[31] L. Jia,et al. The conduct of drug metabolism studies considered good practice (II): in vitro experiments. , 2007, Current drug metabolism.
[32] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[33] J. Condeelis,et al. Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.
[34] H. Bae,et al. Surfactin from Bacillus subtilis displays anti‐proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression , 2007, FEBS letters.
[35] J. Guan,et al. Association of Focal Adhesion Kinase with Tuberous Sclerosis Complex 2 in the Regulation of S6 Kinase Activation and Cell Growth* , 2006, Journal of Biological Chemistry.
[36] T. Adrian,et al. A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. , 2006, Biochemical and biophysical research communications.
[37] G. Rankin,et al. Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide in rats: evidence for bioactivation through alcohol-O-glucuronidation and O-sulfation. , 2005, Chemical research in toxicology.
[38] Erik Sahai,et al. Mechanisms of cancer cell invasion. , 2005, Current opinion in genetics & development.
[39] D. Grant. Detoxification pathways in the liver , 1991, Journal of Inherited Metabolic Disease.
[40] Jos H Beijnen,et al. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. , 2003, Toxicology and applied pharmacology.
[41] J. Slingerland,et al. Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.
[42] D. Ferrari,et al. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. , 2002, Molecular biology of the cell.
[43] S. Ohta,et al. Metabolic activation of bisphenol A by rat liver S9 fraction. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[44] W. Fenical,et al. N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus fusarium. , 2000, Phytochemistry.
[45] T. Hunter,et al. Signal transduction from the extracellular matrix--a role for the focal adhesion protein-tyrosine kinase FAK. , 1996, Cell structure and function.
[46] M. Hamann,et al. Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii. , 1996, Journal of natural products.
[47] A. D. Rodrigues,et al. Use of in vitro human metabolism studies in drug development. An industrial perspective. , 1994, Biochemical pharmacology.